Log In
BCIQ
Print this Print this
 

GLG-401

  Manage Alerts
Collapse Summary General Information
Company GLG Pharma LLC
DescriptionInhibits binding of activated STAT3 dimers to DNA
Molecular Target Signal transducer and activator of transcription 3 (STAT3)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today